Impact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis

Table 2 Treatment Patterns – ANCOVA Analyses

Variable	Mean OROS MPH	Mean TID MPH	Difference	p Value	95% Confidence Interval
15 day Gap in ITT medication	0.85	0.97	0.11	<0.0001	0.0945 – 0.1366
30 day Gap in ITT medication	0.77	0.95	0.17	< 0.0001	0.1510 – 0.2022
Switch to another ADHD med	0.27	0.68	0.41	< 0.0001	0.3802 – 0.4394
Switch to other ITT med	0.01	0.33	0.31	< 0.0001	0.2962 – 0.3271
Days on ITT medication	199.09	107.73	-91.36	< 0.0001	-99.94 – -82.78
90% Compliant	0.24	0.05	-0.1818	< 0.0001	-0.2076 – -0.1560
80% Compliant	0.29	0.07	-0.2227	< 0.0001	-0.2503 – -0.1949
75% Compliant	0.30	0.05	-0.2274	< 0.0001	-0.2554 – -0.1995

ANCOVA results controlling for demographics, general health status, and diagnoses.

ISSN: 1744-859X